MSC来源外泌体治疗缺血性脑卒中机制及进展

曹诗杰; 安红伟

doi:10.12259/j.issn.2095-610X.S20230913

MSC来源外泌体治疗缺血性脑卒中机制及进展

doi: 10.12259/j.issn.2095-610X.S20230913

曹诗杰¹,
安红伟^2, ,

1.
广西中医药大学研究生院，广西南宁　530001
2.
柳州市中医医院脑病科，广西柳州　545001

基金项目: 国家自然科学基金资助项目（82060905）；广西中医药适宜技术与推广基金资助项目（GZSY21-64）

详细信息

作者简介:
曹诗杰（1996～），女，湖北黄石人，在读硕士研究生，主要从事神经病学脑血管疾病研究工作

通讯作者:
安红伟，E-mail：1592188736@qq.com

中图分类号: R743.3
计量
- 文章访问数: 1919
- HTML全文浏览量: 797
- PDF下载量: 30
- 被引次数: 0
出版历程
- 收稿日期: 2023-05-09
- 网络出版日期: 2023-09-23
- 刊出日期: 2023-09-30

Mechanism and Progress of MSC Derived Extracellular Vesicles in the Treatment of Ischemic Stroke

Shijie CAO¹,
Hongwei AN^{2
, ,}

1.
Guangxi University of Chinese Medicine，Nanning Guangxi 530001
2.
Liuzhou Traditional Chinese Medicine Hospital，Liuzhou Guangxi 545001，China

摘要

摘要: 缺血性脑卒中是由于脑动脉血流中断从而导致细胞缺氧和氧化应激，同时激活炎症反应，造成组织细胞损伤，增加细胞凋亡和血液再灌注的风险。间充质干细胞可以通过诱导血管生成来改善缺血性脑卒中程度，同时间充质干细胞还具有抗凋亡，抗炎等诸多功能，被应用于卒中治疗。临床前期研究证实，间充质源外泌体通过靶向传递到受体细胞起到诱导血管生成，抗凋亡和抗炎的效果，也避免了间充质干细胞在治疗过程中存在的不足，进而用于卒中治疗。现系统地对间充质干细胞源外泌体在脑卒中中的作用机理进行总结，为缺血性脑血管病的临床治疗提供一种新的可能性，以期获得更好的治疗效果。
- 间充质干细胞 /
- 外泌体 /
- 脑卒中
Abstract: Cerebral ischemic stoke is a disease in which oxidative stress, activation of inflammatory storms, interference, induction of apoptosis, and blood reperfusion aggravate the tissue and cell damage due to ischemia and hypoxia. Mesenchymal stem cells（MSCs） induce the angiogenesis and can be used to treat the ischemia-reperfusion injury, anti-apoptosis and anti-inflammatory. Preclinical studies have confirmed that targeted delivery of mesenchymal-derived exosomes to recipient cells exerts the effects of inducing angiogenesis, anti-apoptosis, and anti-inflammatory, while avoiding the shortcomings of mesenchymal stem cell therapy. The purpose of this study is to summarize the mechanism of exosomes derived from mesenchymal stem cells in the treatment of stroke so as to provide new opportunities for treating ischemic cerebrovascular disease clinically.
- Mesenchymal stem cells /
- Exosomes /
- Stroke

HTML全文

参考文献(31)

[1]	Donald G Phinney,Mark F Pittenger. Concise review:MSC-derived exosomes for cell-free therapy[J]. Stem Cells (Dayton,Ohio),2017,35(4):851-858. doi: 10.1002/stem.2575
[2]	Zhao Yangmin,Gan Yunxiao,Xu Gewei,et al. MSC-derived exosomes attenuate acute brain injury and inhibit microglial inflammation by reversing cyslt2r-erk1/2mediated microglia M1 polarization[J]. Neurochemical Research,2020,45(5):1180-1190. doi: 10.1007/s11064-020-02998-0
[3]	Jennifer Phan, Priyadarsini Kumar, Dake Hao, et al, Engineering mesenchymal stem cells to improve their exosome efficacy and yield for cell-free therapy [J]. J Extracell Vesicles, 2018, 7（1）: 1522236.
[4]	Farzamfar S,Hasanpour A,Nazeri N,et al. Extracellular micro/nanovesicles rescue kidney from ischemia-reperfusion injury[J]. Journal of Cellular Physiology,2019,234(8):12290-12300. doi: 10.1002/jcp.27998
[5]	Danica Petrovic-Djergovic,Sascha N Goonewardena,David J Pinsky. Inflammatory disequilibrium in stroke[J]. Circulation Research,2016,119(1):142-58. doi: 10.1161/CIRCRESAHA.116.308022
[6]	汪亮. 葛根素对大鼠局灶性脑缺血再灌注损伤后TLR4/NF-κB信号通路的影响[D]. 宁波: 宁波大学博士学位论文, 2012.
[7]	聂金,戴爱国,胡瑞成. 缺氧诱导因子脯氨酸羟化酶的调控与缺血缺氧性疾病[J]. 临床与病理杂志,2007,27(1):53-56. doi: 10.3969/j.issn.1673-2588.2007.01.013
[8]	Yu fang S,Yu W,Qing L,et al. Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases[J]. Nature Reviews Nephrology,2018,14(8):493-507. doi: 10.1038/s41581-018-0023-5
[9]	Tavasolian Fataneh,Moghaddam Abbas Shapouri,Rohani Fattah,et al. Exosomes:Effectual players in rheumatoid arthritis[J]. Autoimmunity Reviews,2020,19(6):102511-102518.
[10]	Zou X,Zhang G,Cheng Z,et al. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1[J]. Stem Cell Research & Therapy,2014,5(2):1-13. doi: 10.1186/scrt428
[11]	Zou Xiangyu,Zhang Guangyuan,Cheng Zhongliang,et al. Microvesicles derived from human Wharton's Jelly mesenchymal stromal cells ameliorate renal ischemia-reperfusion injury in rats by suppressing CX3CL1[J]. Stem Cell Research & Therapy,2014,5(2):40-52.
[12]	Zhao J,Li X,Hu J,et al. Mesenchymal stromal cell-derived exosomes attenuate myocardial ischemia-reperfusion injury through miR-182-regulated macrophage polarization[J]. Cardiovascular Research,2019,115(7):1205-1216. doi: 10.1093/cvr/cvz040
[13]	Liu J,Chen T,Lei P,et al. Exosomes released by bone marrow mesenchymal stem cells attenuate lung injury induced by intestinal ischemia reperfusion via the tlr4-nf-κbpathway[J]. International Journal of Medical[J]. Sciences,2019,16(9):1238-1244. doi: 10.7150/ijms.35369
[14]	Wilson C M,Naves T,Vincent F,et al. Sortilin mediates the release and transfer of exosomes in concert with two tyrosine kinase receptors.[J]. Journal of Cell Science,2014,127(18):3983-3997.
[15]	Sinh N D,Endo K,Miyazawa K,et al. Ets1 and ESE1 reciprocally regulate expression of ZEB1/ZEB2,dependent on ERK1/2 activity,in breast cancer cells[J]. Cancer Science,2017,108(5):952-960. doi: 10.1111/cas.13214
[16]	Long G , Wang F , Duan Q , et al, Human circulating microRNA-1 and microRNA-126 as potential novel indicators for acute myocardial infarction[J]. International Journal of Biological Ences, 2012, 8（6）: 811-818.
[17]	Chen Zhe,Wang Hanqi,Xia Yang,et al. Therapeutic potential of mesenchymal cell–derived miRNA-150-5p–expressing exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF[J]. J Immunol,2018,201(8):2472-2482. doi: 10.4049/jimmunol.1800304
[18]	詹小舒,罗惠娜,罗冬章,等. 犬脐带间充质干细胞来源外泌体对血管内皮细胞增殖、迁移和凋亡的调控作用[J]. 中国组织工程研究,2019,23(29):4637-4643. doi: 10.3969/j.issn.2095-4344.1808
[19]	赵金璇. 间充质干细胞外泌体对心肌缺血再灌注后巨噬细胞极化的影响及作用机制研究[D]. 南京: 南京大学博士学位论文, 2019.
[20]	郝海珍,郭铁,余丹. 脂肪间充质干细胞来源外泌体对脑缺血再灌注大鼠神经元凋亡及炎症因子影响[J]. 第三军医大学学报,2019,41(17):1656-1665. doi: 10.16016/j.1000-5404.201904034
[21]	Wang Z,Xie H,Zhou L,et al. CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma[J]. Oncotarget,2016,7(32):51525-51534. doi: 10.18632/oncotarget.10492
[22]	张娟,史晋叔,李剑. 间充质干细胞源性外泌体—未来生物疗法的理想载体[J]. 中国实验血液学杂志,2015,23(4):1179-1183. doi: 10.1016/j.stem.2009.05.003
[23]	Lee R H,Pulin A A,Seo M J,et al. Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6[J]. Cell Stem Cell,2009,5(1):54-63.
[24]	Merino-González C,Zuñiga F A,Escudero C,et al. Mesenchymal stem cell-derived extracellular vesicles promote angiogenesis: Potencial clinical application[J]. Frontiers in Physiology,2016,7(24):24-32.
[25]	Ravichandran R,Itabashi Y,Liu W,et al. A decline in club cell secretory proteins in lung transplantation is associated with release of natural killer cells exosomes leading to chronic rejection.[J]. The Journal of Heart and Lung Transplantation:The Official Publication of the International Society for Heart Transplantation,2021,40(12):1517-1528. doi: 10.1016/j.healun.2021.08.016
[26]	Riazifar M,Mohammadi M R,Pone E J,et al. Stem cell-derived exosomesas nanotherapeutics for autoimmune and neurodegenerative disorders[J]. Acs Nano,2019,13(6):6670-6688. doi: 10.1021/acsnano.9b01004
[27]	Zhuang X,Xiang X,Grizzle W,et al. Treatment of brain inflammatory diseases by delivering exosomeencapsulated anti-inflammatory drugs from the nasal region to the brain[J]. Mol Ther,2011,19(10):1769-1779.
[28]	Jiang X C, Gao J Q. Exosomes as novel bio-carriers for gene and drug delivery[J]. Int J Pharm,2017,521(1-2):167-175.
[29]	Xin H,Li Y,Buller B,et al. Exosome-mediated transfer of miR-133b from multipotent mesenchymal stromal cells to neural cells contributes to neurite outgrowth[J]. Stem Cells,2012,30(7):1556-1564.
[30]	Xu W,Yang Z,Lu N. From pathogenesis to clinical application: Insights into exosomes as transfer vectors in cancer[J]. Journal of Experimental & Clinical Cancer Research Cr,2016,35(1):156-167.
[31]	Wang J,Li W,Lu Z,et al. The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis[J]. Nanoscale,2017,9(40):15598-15605. doi: 10.1039/C7NR04425A

相关文章(20)

[1]	朱磊, 李瑞雪, 鲍长磊, 黄晨宸, 梁书鑫, 赵振林, 朱洪. MSC-exo一种新型细胞递送工具转运靶向基因调控胰腺癌增殖效应分析, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20240206
[2]	夏斯亚, 杨明莹, 刘玉芹, 孟庭瑞, 李霖荣, 胡倚琦, 肖遥. 脑卒中吞咽障碍患者照顾者对进食知识与技能需求调查研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230319
[3]	何思锦, 陈小霞, 陈奇刚, 赵荣, 刘朵, 廖映迪, 李黛颖, 顾力华. 基于“中枢-外周-中枢”闭环康复理论运用头针联合吞咽治疗仪治疗脑卒中后吞咽困难的临床疗效研究, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230802
[4]	张梁, 王保全, 雷喜锋, 王旭, 柯阳, 张玮. M2巨噬细胞来源的外泌体miR-1246调控胃癌细胞的生长和侵袭, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20230724
[5]	王静, 朱真真, 白钰璇, 贾志彬, 任燕龙. 脑卒中后吞咽功能障碍继发吸入性肺炎的危险因素, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220214
[6]	张四美, 房红梅, 杨晰宸, 宁蓉, 龙毅坚, 李蕊, 金亚菊. 双向折镜多维空间感觉刺激治疗脑卒中单侧忽略疗效观察, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20221224
[7]	顾君, 何泽喜, 栾婷, 王海峰, 王剑松, 丁明霞. 外泌体长链非编码RNA在膀胱癌中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220110
[8]	张天红, 杨红菊. 外泌体miRNA在肝细胞癌中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20220221
[9]	李蕊, 张萍, 魏鲁刚, 房红梅, 王刘艳, 卢静怡, 陈曦, 杨菊. MHI对脑卒中患者膈肌运动和肺功能的临床疗效, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210616
[10]	房红梅, 苏国栋, 魏鲁刚, 李蕊, 吴莎, 龙毅坚. MHI技术对改善脑卒中患者膈肌运动幅度与BI指数的临床疗效, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210205
[11]	蔡啸, 扆雪涛, 姚菁青, 戴昕妤, 汤忠泉, 欧婷, 赵晓敏, 李云涛. 人骨髓间充质干细胞分泌的外泌体调控恶性胶质瘤相关巨噬细胞的极化, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210101
[12]	马丽娅, 饶南荃, 杨禾丰. 间充质干细胞外泌体在口腔组织再生中的研究进展, 昆明医科大学学报. doi: 10.12259/j.issn.2095-610X.S20210527
[13]	魏韩笑, 张爱君, 李强, 金培生. 血管内皮祖细胞外泌体调控骨髓间充质干细胞基因表达谱芯片, 昆明医科大学学报.
[14]	谢晓燕, 程元, 程贤琴, 杜蓉, 刘晓玲, 倪梓桐, 潘泓频. 早期吞咽功能训练对脑卒中气管切开患者快速康复的影响, 昆明医科大学学报.
[15]	贾凤梅, 殷顺会, 冉丽权, 田明彤, 张明珠. 特发性牙龈纤维瘤来源外泌体对正常牙龈细胞周期的影响, 昆明医科大学学报.
[16]	於晓东, 龙江. 12外泌体对体外血脑屏障模型功能的影响, 昆明医科大学学报.
[17]	李蕊, 魏鲁刚, 杨艳, 张林森, 张洪秀. 脑卒中低肌张力患者超声引导下外周神经电刺激的临床对照, 昆明医科大学学报.
[18]	谢作舟. 支气管镜在老年脑卒中并重症肺炎患者治疗中的应用, 昆明医科大学学报.
[19]	任玲. 120与脑外科紧密配合提高脑卒中抢救成功率, 昆明医科大学学报.
[20]	杨锋. 两种培养方法在猪自体骨髓间充质干细胞培养的比较研究, 昆明医科大学学报.